VIDEO: More Than Half of Those Who Stop GLP-1s Restart Within a Year
A comprehensive retrospective cohort study presented at the ENDO 2026 annual meeting has uncovered significant fluctuations in how patients utilize…
A comprehensive retrospective cohort study presented at the ENDO 2026 annual meeting has uncovered significant fluctuations in how patients utilize…
On July 15, a landmark coalition of 38 professional medical, patient advocacy, and research organizations, led by the Endocrine Society,…
On July 14, the Centers for Medicare & Medicaid Services (CMS) officially released the proposed rule for the Calendar Year…
The Intersection of Hypercortisolism and Metabolic Disease Endogenous Cushing’s syndrome is a rare and complex endocrine disorder characterized by the…
The medical community has long debated the efficacy of testosterone replacement therapy (TRT) as a potential tool for managing metabolic…
Ascendis Pharma A/S, a biopharmaceutical company headquartered in Copenhagen, Denmark, recently announced significant clinical and commercial updates regarding its therapeutic…
Following the conclusion of ENDO 2026 in Chicago, Illinois, the Endocrine Society has pivoted its focus toward a robust autumn…
The integration of artificial intelligence into clinical practice has transitioned from a speculative future to a tangible necessity, a shift…
The landscape of endocrine research is undergoing a transformative shift as early-career scientists introduce novel perspectives on metabolic regulation, particularly…
The Clinical Challenge of Post-Bariatric Hypoglycemia Post-bariatric hypoglycemia is a chronic and often debilitating metabolic complication that arises in a…